Hmmm...JustMyOpinion...oldmanbadman rdncoic
Ok, this is just my opinion and that is all it is. The continued buying today is proof, that someone knows about some sort of good news on the market with BMRA. People taking profit but the share price fails to fall because someone is buying and buying big. And they have a broker doing the buying so as not to run the Share Price up. If you or I were buying, well the Share Price would really be up on almost 100,000 shares bought and sold.
So little shareholders like us should be careful not to sell too soon. The old addage, "Buy on the Rumor, and Sell on the News" is going to be my mantra here.
Now I am going to be a little silent here and watch BMRA do some nice things for me. I need a new pool and a new garage. :) :) :) oldmanbadman rdncoic
U got BMRA? U B Bad or U B Sad!
Ok, this is just my opinion and that is all it is. The continued buying today is proof, that someone knows about some sort of good news on the market with BMRA. People taking profit but the share price fails to fall because someone is buying and buying big. And they have a broker doing the buying so as not to run the Share Price up. If you or I were buying, well the Share Price would really be up on almost 100,000 shares bought and sold.
So little shareholders like us should be careful not to sell too soon. The old addage, "Buy on the Rumor, and Sell on the News" is going to be my mantra here.
Now I am going to be a little silent here and watch BMRA do some nice things for me. I need a new pool and a new garage. :) :) :) oldmanbadman rdncoic
U got BMRA? U B Bad or U B Sad!
Recent BMRA News
- Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development • GlobeNewswire Inc. • 05/28/2026 12:19:00 PM
- Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 • GlobeNewswire Inc. • 04/29/2026 12:19:00 PM
- Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway • GlobeNewswire Inc. • 04/16/2026 12:19:00 PM
- Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs • GlobeNewswire Inc. • 04/14/2026 12:19:00 PM
- Biomerica Reports Third Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 04/13/2026 10:57:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/13/2026 09:15:20 PM
- Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe • GlobeNewswire Inc. • 03/18/2026 12:19:00 PM
- Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain • GlobeNewswire Inc. • 03/05/2026 01:19:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2026 10:15:26 PM
- Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy • GlobeNewswire Inc. • 02/26/2026 01:19:00 PM
- Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution • GlobeNewswire Inc. • 02/18/2026 01:19:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:40:25 PM
- Biomerica Reports Second Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 01/14/2026 10:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/14/2026 10:15:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2025 10:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2025 10:10:03 PM
- Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test • GlobeNewswire Inc. • 12/23/2025 01:19:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 01:19:33 PM
- Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio • GlobeNewswire Inc. • 12/11/2025 01:08:00 PM
- Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS • GlobeNewswire Inc. • 11/25/2025 01:19:00 PM
- Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand • GlobeNewswire Inc. • 11/06/2025 01:19:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/23/2025 08:15:04 PM
- Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. • GlobeNewswire Inc. • 10/16/2025 12:19:00 PM
- Biomerica Reports First Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 10/15/2025 01:27:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/14/2025 09:11:06 PM
